(S1 (S (S (NP (NP (DT A) (JJ novel) (NN integrin) (NN alpha5beta1) (JJ antagonistic) (NN peptide)) (, ,) (NP (NN A5-1)) (, ,)) (VP (VBN screened) (PP (IN by) (NP (NN Protein) (NN Chip) (NN system))) (PP (IN as) (NP (DT a) (JJ potent) (NN angiogenesis) (NN inhibitor))))) (. .)))
(S1 (S (S (NP (NP (NN Integrin) (NN alpha5beta1)) (VP (VBN immobilized) (PP (IN on) (NP (DT a) (NN ProteoChip))))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB screen) (NP (JJ new) (JJ antagonistic) (NNS peptides)) (PP (IN from) (NP (NP (JJ multiple) (NN hexapeptide) (NNS sub-libraries)) (PP (IN of) (NP (NP (DT the) (JJ positional) (NN scanning) (JJ synthetic) (NN peptide) (JJ combinatorial) (NN library)) (PRN (-LRB- -LRB-) (NP (NN PS-SPCL)) (-RRB- -RRB-)))))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN integrin) (NN alpha5beta1-Fibronectin) (NN interaction)) (VP (VBD was) (VP (VBN demonstrated) (PP (IN on) (NP (DT the) (NN chip)))))) (. .)))
(S1 (S (S (NP (NP (NP (DT A) (JJ novel) (NN peptide) (NN ligand)) (, ,) (NP (NP (NN A5-1)) (PRN (-LRB- -LRB-) (NP (NN VILVLF)) (-RRB- -RRB-))) (, ,)) (PP (IN with) (NP (JJ high) (NN affinity))) (PP (TO to) (NP (NN integrin) (NN alpha5beta1)))) (VP (VBD was) (VP (VBN identified) (PP (IN from) (NP (NP (DT the) (NN hexapeptide) (NNS libraries)) (PP (IN with) (NP (DT this) (JJ chip-based) (NN screening) (NN method))))) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT a) (JJ competitive) (NN inhibition) (NN assay)))))))) (. .)))
(S1 (S (S (NP (NN A5-1)) (VP (VBZ inhibits) (NP (DT the) (JJ integrin-fibronectin) (NN interaction)) (PP (IN in) (NP (NP (DT a) (JJ dose-dependent) (NN manner)) (PRN (-LRB- -LRB-) (NP (NN IC-LRB-50-RRB-) (: ;) (CD 1.56+/-0.28) (NN microM))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP it)) (VP (VBZ inhibits) (NP (NP (NP (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NN cell) (NN proliferation)) (, ,) (NP (NN migration)) (, ,) (NP (NN adhesion)) (, ,) (NP (JJ tubular) (NN network) (NN formation)) (, ,) (CC and) (NP (JJ bFGF-induced) (NN neovascularization))) (PP (IN in) (NP (DT a) (NN chick) (JJ chorioallantoic) (NN membrane)))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN A5-1)) (VP (MD will) (VP (VB be) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN neovascularization)))))))))) (. .)))
